Link between gut‐microbiome derived metabolite and shared gene‐effects with hepatic steatosis and fibrosis in NAFLD

Cited by (208)

Items 101–200 of 208

1. Microbial Products and Metabolites Contributing to Alcohol‐Related Liver Disease
   Bei Gao, Atoosa Emami, Shilpa Nath, Bernd Schnabl · 2020 · Molecular Nutrition & Food Research
2. Neutrophil: An emerging player in the occurrence and progression of metabolic associated fatty liver disease
   Shiwei Chen, Huiting Guo, Mingjie Xie, Cheng Zhou, Min Zheng · 2021 · International Immunopharmacology
3. Clinical Application and Progress of Fecal Microbiota Transplantation in Liver Diseases: A Review
   Xinpei Gu, Qin Lu, Chengcheng Zhang, Zhewei Tang, Liuxi Chu · 2021 · Seminars in Liver Disease
4. Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases
   Satya Priya Sharma, Ki Tae Suk, Dong Joon Kim · 2021 · World Journal of Gastroenterology
5. Physical exercise plays a role in rebalancing the bile acids of enterohepatic axis in non‐alcoholic fatty liver disease
   Minyu Zhang, Biyang Xiao, Xiaoqi Chen, Bingming Ou, Songtao Wang · 2023 · Acta Physiologica
6. Immunological dynamics in MASH: from landscape analysis to therapeutic intervention
   Lawan Rabiu, Pengchao Zhang, L. O. Afolabi, M. Saliu, Salisu M. Dabai, R. B. Suleiman, Khalid I Gidado, M. A. Ige, Abdulrahman Ibrahim, Gui-Zhong Zhang et al. · 2024 · Journal of gastroenterology
7. Double Trouble: How Microbiome Dysbiosis and Mitochondrial Dysfunction Drive Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
   Wesam Bahitham, Siraj Alghamdi, Ibrahim Omer, Ali Saleh Alsudais, Ilana Hakeem, Arwa Alghamdi, Reema Abualnaja, Faisal M. Sanai, Alexandre Soares Rosado, Consolato Maria Sergi · 2024 · Biomedicines
8. Nonalcoholic fatty liver disease and the gut microbiome: Are bacteria responsible for fatty liver?
   Tien Sy Dong, Jonathan P. Jacobs · 2019 · Experimental Biology and Medicine
9. Lactate exacerbates lung damage induced by nanomicroplastic through the gut microbiota–HIF1a/PTBP1 pathway
   Lihui Xuan, Zheng Xu, Jinhua Luo, Yin Wang, Yuhui Yan, Can Qu, Zuozhong Xie, Magdalena Skonieczna, Ping‐Kun Zhou, Ruixue Huang · 2023 · Experimental & Molecular Medicine
10. Implication of the Gut Microbiota in Metabolic Inflammation Associated with Nutritional Disorders and Obesity
    Julie Rodriguez, Marta Olivares, Nathalie M. Delzenne · 2020 · Molecular Nutrition & Food Research
11. Microbial modifications with Lycium barbarum L. oligosaccharides decrease hepatic fibrosis and mitochondrial abnormalities in mice
    Zheng Zhang, Wenjia Lu, Pengfei Liu, Mengjie Li, Xinyi Ge, Bin Yu, Zhengzong Wu, Guimei Liu, Nannan Ding, Bo Cui et al. · 2023 · Phytomedicine
12. Gut microbiome and metabolic dysfunction-associated steatotic liver disease: Pathogenic role and potential for therapeutics
    Sandra G. García, Debora Rondinella, Francesca Romana Ponziani, Luca Miele, Antonio Gasbarrini, Giovanni Cammarota, Ángel Lanas, Fernando Gomollón · 2024 · Best Practice & Research Clinical Gastroenterology
13. Unraveling Mechanisms of Genetic Risks in Metabolic Dysfunction–Associated Steatotic Liver Diseases: A Pathway to Precision Medicine
    Xiang Zhang, Kyong‐Mi Chang, Jun Qing Yu, Rohit Seth Loomba · 2025 · Annual Review of Pathology Mechanisms of Disease
14. The New Paradigm of Non-Alcoholic Fatty Liver Disease: Phenotypic Diversity of Metabolically Associated Fatty Liver Disease
    Ye.V. Vinnitskaya, Yu.G. Sandler, Dmitry S. Bordin · 2020 · Effective Pharmacotherapy
15. Probiotic yogurt regulates gut microbiota homeostasis and alleviates hepatic steatosis and liver injury induced by high‐fat diet in golden hamsters
    Linwensi Zhu, Na Ying, Liuyi Hao, Ai Fu, Qinchao Ding, Feiwei Cao, Daxi Ren, Qiang Han, Songtao Li · 2024 · Food Science & Nutrition
16. Gut microbiome responses in the metabolism of human dietary components: Implications in health and homeostasis
    Riya Rajeev, P. S. Seethalakshmi, Prasant Kumar Jena, Ragothaman Prathiviraj, George Seghal Kiran, Joseph Selvin · 2021 · Critical Reviews in Food Science and Nutrition
17. Sirtuins and Gut Microbiota: Dynamics in Health and a Journey from Metabolic Dysfunction to Hepatocellular Carcinoma
    Mahmoud Zhra, Muhammad Affan Elahi, Aamira Tariq, Ahmed Abu‐Zaid, Ahmed Yaqinuddin · 2025 · Cells
18. Targeted inhibition of pathobiont virulence factor mitigates alcohol-associated liver disease
    Yongqiang Yang, Yi Duan, Sonja Lang, Marcos F. Fondevila, David Schöler, Aenne Harberts, Noemí Cabré, Sainan Chen, Yan Shao, Kévin Vervier et al. · 2025 · Cell Host & Microbe
19. Multi-Channel Metabolomics Analysis Identifies Novel Metabolite Biomarkers for the Early Detection of Fatty Liver Disease in Dairy Cows
    Xuan Zhang, Tingjun Liu, Xianpeng Hou, Chengzhang Hu, Letian Zhang, Shengxuan Wang, Qin Zhang, Kerong Shi · 2022 · Cells
20. Gochujang Ameliorates Hepatic Inflammation by Improving Dysbiosis of Gut Microbiota in High-Fat Diet-Induced Obese Mice
    Eun-Ji Lee, Olivet Chiamaka Edward, Eun-Bi Seo, Eun‐Gyung Mun, Su-Ji Jeong, Gwangsu Ha, Anna Han, Youn‐Soo Cha · 2023 · Microorganisms
21. Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring
    Natalia Balassiano Wajsbrot, Nathalie Carvalho Leite, Gil Fernando Salles, Cristiane Alves Villela‐Nogueira · 2022 · World Journal of Gastroenterology
22. Gut microbiome in liver pathophysiology and cholestatic liver disease
    Shengmin Yan, Xiao‐Ming Yin · 2021 · Liver Research
23. Expanding germ-organ theory: Understanding non-communicable diseases through enterobacterial translocation
    Seenivasan Boopathi, P. Snega Priya, B. Haridevamuthu, S.P. Ramya Ranjan Nayak, Munisamy Chandrasekar, Jesu Arockiaraj, Ai‐Qun Jia · 2023 · Pharmacological Research
24. Therapeutic approaches for non-alcoholic steatohepatitis
    Luc F. Van Gaal, Jonathan Mertens, Sven Francque, Christophe E.M. De Block · 2021 · Therapeutic Advances in Endocrinology and Metabolism
25. Gut microbial metabolites of amino acids in liver diseases
    Mengyao Hu, Yi Xu, Hongwei Zhou, Xiaolong He · 2025 · Gut Microbes
26. Roles of gut microbes in metabolic-associated fatty liver disease
    Chun‐Yao Chen, Han‐Chen Ho · 2023 · Tzu Chi Medical Journal
27. Long‐term efficacy of washed microbiota transplantation in overweight patients
    Dejiang Lin, Dongxia Hu, Youlin Song, Xing‐Xiang He, Lei Wu · 2024 · European Journal of Clinical Investigation
28. Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitis
    Monica A. Tincopa · 2020 · Endocrinology Diabetes & Metabolism
29. Phosphate Groups in the Lipid A Moiety Determine the Effects of LPS on Hepatic Stellate Cells: A Role for LPS-Dephosphorylating Activity in Liver Fibrosis
    Marlies Schippers, Eduard Post, Ilse A. Eichhorn, Jitske Langeland, Leonie Beljaars, Madhu S. Malo, Richard A. Hodin, José Luís Millán, Yury V. Popov, Detlef Schuppan et al. · 2020 · Cells
30. Manipulating the Gut Microbiome to Alleviate Steatotic Liver Disease: Current Progress and Challenges
    Ernesto Saenz, Nathally Espinosa Montagut, Baohong Wang, Christoph K. Stein-Thöringer, Kaicen Wang, Honglei Weng, Matthias P. Ebert, Kai Markus Schneider, Lanjuan Li, Andreas Teufel · 2024 · Engineering
31. Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Salim Maher, Jayashi Rajapakse, Emad M. El-Omar, Amany Zekry · 2024 · Seminars in Liver Disease
32. Effects of Saccharomyces boulardii on microbiota composition and metabolite levels in the small intestine of constipated mice
    Shuai Tang, Jia Li, Yi Li, Haitao Du, Wenya Zhu, Ru Zhang, Jun Wan · 2024 · BMC Microbiology
33. Gut metagenome‐derived signature predicts hepatic decompensation and mortality in NAFLD‐related cirrhosis
    Suzanne R. Sharpton, Tae Gyu Oh, Egbert V. Madamba, Chenjingyi Wang, Ruth T. Yu, Annette R. Atkins, Tao Huan, Michael Downes, Ronald M. Evans, Rohit Seth Loomba · 2022 · Alimentary Pharmacology & Therapeutics
34. Interventions for non-alcoholic liver disease: a gut microbial metabolites perspective
    Jin Guo, Chunxia Shi, Qingqi Zhang, Wei Deng, Luyi Zhang, Qian Chen, Danmei Zhang, Zuojiong Gong · 2022 · Therapeutic Advances in Gastroenterology
35. A new insight: crosstalk between neutrophil extracellular traps and the gut-liver axis for nonalcoholic fatty liver disease
    Jinping Yin, Yanli Zhu, Rongrong Liu, Weixin Wang, Zhicheng Wang, Jianfeng Wang · 2025 · Frontiers in Immunology
36. Univariate and Multivariate Statistical Analysis of Microbiome Data: An Overview
    Hani Aldirawi, Franceskrista G. Morales · 2023 · Applied Microbiology
37. Gochujang, a Korean traditional fermented soybean product: history, preparation and functionality
    Su‐Jin Jung, Dong-Hwa Shin · 2024 · Journal of Ethnic Foods
38. Net release and uptake of xenometabolites across intestinal, hepatic, muscle, and renal tissue beds in healthy conscious pigs
    Kelly E. Mercer, Gabriëlla A. M. Ten Have, Lindsay Pack, Renny Shang-Lun Lan, Nicolaas E.P. Deutz, Sean H. Adams, Brian D. Piccolo · 2020 · American Journal of Physiology-Gastrointestinal and Liver Physiology
39. In Vitro Modulatory Effect of Stevioside, as a Partial Sugar Replacer in Sweeteners, on Human Child Microbiota
    Florentina Gatea, Ionela Sârbu, Emanuel Vamanu · 2021 · Microorganisms
40. Relationships and Mendelian Randomization of Gut Microbe-Derived Metabolites with Metabolic Syndrome Traits in the METSIM Cohort
    Sahereh Mirzaei, Holli A. DeVon, R. Cantor, A. Cupido, Calvin Pan, Min-Ha Sung, Lilian Fernandes Silva, James R. Hilser, J. Hartiala, H. Allayee et al. · 2024 · Metabolites
41. Gut microbes combined with metabolomics reveal the protective effects of Qijia Rougan decoction against CCl4-induced hepatic fibrosis
    Xue Li, Xinyi Xu, Sian Tao, Yue Su, Li Wen, Dong Wang, Jibin Liu, Quansheng Feng · 2024 · Frontiers in Pharmacology
42. Role of Probiotics in Gut Microbiome and Metabolome in Non-Alcoholic Fatty Liver Disease Mouse Model: A Comparative Study
    Tian Wu, Zheng Zeng, Yanyan Yu · 2024 · Microorganisms
43. Clinical improvement effect of regulating gut microbiota on metabolic dysfunction-associated steatotic liver disease: Systematic review and meta-analysis of randomized controlled trials
    Juan Wu, Xiaoyang Chen, Jun Qian, Guochun Li · 2024 · Clinics and Research in Hepatology and Gastroenterology
44. The Role of the Gut–Biliary–Liver Axis in Primary Hepatobiliary Liver Cancers: From Molecular Insights to Clinical Applications
    Mario Romeo, Marcello Dallio, Fiammetta Di Nardo, Carmine Napolitano, Paolo Vaia, Giuseppina Martinelli, Pierluigi Federico, Simone Olivieri, Patrizia Iodice, Alessandro Federico · 2025 · Journal of Personalized Medicine
45. Metabolic drivers of MASLD and MASH: from hormonal imbalance to fibrosis
    Amalia Gastaldelli, Egeria Scoditti, Maria Paula Macedo · 2026 · Diabetologia
46. An Update on the Role of the Microbiome in Non-alcoholic Fatty Liver Disease Pathogenesis, Diagnosis, and Treatment
    Marialena Mouzaki, Rohit Seth Loomba · 2020 · Current Treatment Options in Gastroenterology
47. Gut microbiome profiles associated with steatosis severity in metabolic associated fatty liver disease
    Tien Sy Dong, Kayti Luu, Venu Lagishetty, Farzaneh Sedighian, Shih‐Lung Woo, Benjamin W. Dreskin, William R. Katzka, Candace Chang, Yi Zhou, Nerea Arias-Jayo et al. · 2021 · Hepatoma Research
48. Tocotrienol Supplementation Led to Higher Serum Levels of Lysophospholipids but Lower Acylcarnitines in Postmenopausal Women: A Randomized Double-Blinded Placebo-Controlled Clinical Trial
    Chwan‐Li Shen, Huanbiao Mo, Dale M. Dunn, Bruce A. Watkins · 2021 · Frontiers in Nutrition
49. Gut ecological networks reveal associations between bacteria, exercise, and clinical profile in non-alcoholic fatty liver disease patients
    Susanne Csader, Xiuqiang Chen, Howell Leung, Ville Männistö, Heikki Pentikäinen, Milla‐Maria Tauriainen, Kai P. Savonen, Hani S El-Nezami, Ursula Schwab, Gianni Panagiotou · 2023 · mSystems
50. Insights Into Intestinal Flora in Metabolic Dysfunction‐Associated Steatotic Liver Disease
    Zechen Xin, Ziyuan Wang, Ming Chu · 2025 · The FASEB Journal
51. The Intestinal Microbiome, Plasma Metabolome, and Liver Transcriptome: A Conspiracy Driving Hepatic Steatosis
    Wajahat Zafar Mehal, Rohit Seth Loomba · 2019 · Hepatology
52. M 2 IA: a Web Server for Microbiome and Metabolome Integrative Analysis
    Yan Ni, Gang Yu, Huan Chen, Yongqiong Deng, Philippa M Wells, Claire Joanne Steves, Feng Ju, Junfen Fu · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
53. The role of bacterial metabolites derived from aromatic amino acids in non-alcoholic fatty liver disease
    Elena S. Shcherbakova, Tatyana S. Sall, Stanislav I. Sitkin, Timur Vakhitov, Elena V. Demyanova · 2020 · Almanac of Clinical Medicine
54. Effect of environmental variance-based resilience selection on the gut metabolome of rabbits
    Cristina Casto‐Rebollo, M. J. Argente, M. L. García, A. Blasco, Noelia Ibáñez‐Escriche · 2023 · Genetics Selection Evolution
55. Influence of Gut Microbiota and its Metabolites on Progression of Metabolic Associated Fatty Liver Disease
    Yuan-yuan Wang, Hailian Lin, Ke-Lang Wang, Genxiang Que, Ting Cao, La-Mei Zhu, Xia Yang, Xuefeng Yang · 2023 · Chinese Medical Sciences Journal
56. Hígado graso (parte 1): aspectos generales, epidemiología, fisiopatología e historia natural
    Jhon Edison Prieto Ortíz, Carlos Bernardo Sánchez Luque, Rolando José Ortega Quiróz · 2022 · Revista Colombiana de Gastroenterología
57. Identification of the keystone species in non-alcoholic fatty liver disease by causal inference and dynamic intervention modeling
    Dingfeng Wu, Na Jiao, Ruixin Zhu, Yida Zhang, Wenxing Gao, Sa Fang, Yichen Li, Sijing Cheng, Chuan Tian, Ping Lan et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
58. Gut microbiome synthesizes important core metabolites to prevent cognitive decline and mitigate onset and progression of Alzheimer's disease
    Nouf S. Al-Abbas, Nehad A. Shaer · 2024 · Journal of Alzheimer s Disease Reports
59. A gut microbiome-kidney-heart axis predictive of future cardiovascular diseases
    Kanta Chechi, Rima Chakaroun, Antonis Myridakis, Sofia Kirke Forslund, Sebastien Fromentin, Trine Nielsen, Judith Aron‐Wisnewsky, Eugeni Belda, Edi Prifti, Pierre Bel Lassen et al. · 2026 · Nature Communications
60. The role of probiotics in adolescents’ obesity
    Xiaoping Chen, You Li, Yong Jia · 2025 · Frontiers in Cellular and Infection Microbiology
61. Prebiotic‐Based Nanoamorphous Atorvastatin Attenuates Nonalcoholic Fatty Liver Disease by Retrieving Gut and Liver Health
    Jin‐Jin Cui, Rui Li, Xiaolei Ma, Haoyang Yu, Zhigang Luo, Peng Du, Ling Ren, Xiao Ding, Xiuping Guo, Wensheng Zheng et al. · 2023 · Small Structures
62. Causal relationship between gut microbiota, metabolites, and short stature: a Mendelian randomization study
    Zhimin Zheng, Hao Sun, Panpan Zhang, Fan Cao, Xuwu Xiao, Tingting Zhao · 2025 · Pediatric Research
63. Microbiota encroachment and a gut-adipose-liver axis in metabolic dysfunction-associated steatotic liver disease
    DARIA A. IGUDESMAN, Gongxin Yu, Charlène J. G. Dauriat, Torfay Roman, Maryam R. Kashi, Elizabeth A Blakley, Benoît Chassaing, Karen D. Corbin · 2025 · American Journal of Physiology-Gastrointestinal and Liver Physiology
64. Characteristics of Urine Organic Acid Metabolites in Nonalcoholic Fatty Liver Disease Assessed Using Magnetic Resonance Imaging with Elastography in Korean Adults
    Ji-Hee Haam, Yun Kyong Lee, Eunkyung Suh, Young‐Sang Kim · 2022 · Diagnostics
65. Radiobioinformatics: A novel bridge between basic research and clinical practice for clinical decision support in diffuse liver diseases
    Pinggui Lei, Na Hu, Yuhui Wu, Maowen Tang, Lin Chong, Luoyi Kong, Lingfeng Zhang, Peng Luo, Lawrence Chan · 2023 · iRadiology
66. Fermentation of Polygonati Rhizoma aqueous extract using Lactiplantibacillus plantarum under the condition of eutrophication
    Ziling Wang, Jia Lao, Zhenni Xie, Wei He, Can Zhong, Shui-Han Zhang, Jian Jin · 2024 · Archives of Microbiology
67. Intrahepatic Cholestasis in Non-Alcoholic Fatty Liver Disease: Pathogenesis and Role of Ademetionine in Treatment
    Elena N. Shirokova · 2023 · Russian Journal of Gastroenterology Hepatology Coloproctology
68. The Impact of Gut Microbiota on Mental Health
    Mahmoud Tarek Hefnawy, Kholoud Elsamman, Abdallah Abbas, Yousef Hawas · 2024 · Nutritional neurosciences
69. Methodology for the determining aromatic monocarboxylic acids as products of phenylalanine and tyrosine metabolism: current advances and trends
    Konstantin Yu. Zhizhin, Eugeniy S. Turyshev, Aliсa K. Pautova, Beloborodova Nv, Н. Т. Кузнецов · 2024 · Russian Chemical Reviews
70. Comparative genomic and metabolomic analysis reveals the potential of a newly isolated Enterococcus faecium B6 involved in lipogenic effects
    Wei Ping Jia, Jiayou Luo, Fei Yang, Wen Dai, Zhihang Huang, Yulin Yan, Miyang Luo · 2024 · Gene
71. Serum Metabolomic Markers of Dietary Potassium and Risk of CKD
    Lauren Bernard, Jiaqi Yang, Jingsha Chen, Valerie K. Sullivan, Bing Yu, Eugene P. Rhee, Paul A. Welling, Casey M. Rebholz · 2025 · Clinical Journal of the American Society of Nephrology
72. Exploring the Classic and Novel Pathogenetic Insights of Plastic Exposure in the Genesis and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Mario Romeo, Marcello Dallio, Fiammetta Di Nardo, Giuseppina Martinelli, Claudio Basile, Alessia Silvestrin, Giusy Senese, Annachiara Coppola, Carmine Napolitano, Angela Amoresano et al. · 2025 · Livers
73. Comparable Long-Term Liver Transplant Outcomes in Primary Sclerosing Cholangitis with and without MASLD: Last Decade Analysis of the UNOS Database
    Leandro Sierra, Natchaya Polpichai, Nazlı Begüm Öztürk, Lynette M. Sequeira, Eleazar Enrique. Montalvan-Sanchez, Nikki K. Duong · 2025 · Digestive Diseases
74. Microbiota and fatty liver disease: Potential candidate for therapeutic intervention
    Majid Eslami, Ramtin Naderian, Mahdieh Tarahomi, Ali Babaeizad, Parya Amini, Pegah Pouya · 2025 · Elsevier eBooks
75. The gut-liver/bile axis: Gut microbiota and bacterial extracellular vesicles remodeling hepatobiliary pathogenesis
    Siyang Hu, Chunhui He, Kunqi Sun, Hongye Zhou, Xueyan Liu, Dr. Hao Wang, Sen Li, Haifeng Yu, Ke Xu, Wei Li · 2026 · iScience
76. Metabolic Dysfunction‐Associated Fatty Liver Disease: From Pathogenesis to Treatment
    Zhifu Cui, Xiaxia Du, Felix Kwame Amevor, Yaoyao Xia, You Yang, Lingbin Liu · 2026 · MedComm
77. Gut Microbiome and Hepatic Steatosis (Steatotic Liver Disease)
    Lesley Hoyles · 2023 · Endocrinology
78. Prävention der nicht-alkoholischen Steatohepatitis (NASH) und deren Folgeerkrankungen
    Yvonne Huber, Jörn Markus Schattenberg · 2020 · Springer eBooks
79. Dysimilarities In The Gut Metabolome Of Rabbits With Genetic Differences In Their Resilient Potential
    Cristina Casto‐Rebollo, M. J. Argente, M. L. García, A. Blasco, Noelia Ibáñez‐Escriche · 2022 · Research Square
80. The gut microbiome and gut-liver axis in NAFLD
    Chuanyong Guo, Jie Ji, Jianye Wu, Liwei Wu, Jiao Feng, Jingjing Li, Qiang Yu, Weiqi Dai, Yan Li, Yuanyuan Zheng · 2024
81. An Integrated Multi-omics Mendelian Randomization Identifies Predictive Transcription Gene Signature of Liver Fibrosis
    Xiaoyan Wang, Lin Zhang, Yuhao Chang, Yuhuai Guo, Guangze Yang, Wenjun Xie, Min Zhu, Jisi Teng, Jessie Shen, Wei Jia et al. · 2024 · Research Square
82. Targeting fibrosis: Identification and characterisation of chemical and genetic modulators of collagen expression
    V. Chand · 2023 · Queensland University of Technology
83. N-acetyl-phenylalanine induces hepatic steatosis in MASLD by disrupting ER-mitochondria calcium coupling and mitochondrial lipid oxidation
    Rémy Lefebvre, Theo Rousseaux, Nadia Bendridi, Stéphanie Chanon, Delphine Arquier, Alexandre Humbert, Nicolas Bertocchini, Bruno Pillot, Emmanuelle Meugnier, Aurélie Vieille‐Marchiset et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
84. Is non-alcoholic steatohepatitis caused by alcohol?
    Hubert Erich Blum · 2020 · Archives of Community Medicine and Public Health
85. Mistranslation drives alterations in protein levels and the effects of a synonymous variant at the FGF21 locus
    Ali Bayoumi · 2020 · The Sydney eScholarship Repository (The University of Sydney)
86. Gut Microbiota and the Liver: Interaction Shaping Interactome
    Priti Devi, Azka Khan, Partha Chattopadhyay, Aarushi Garg, Rajesh Pandey · 2021 · Elsevier eBooks
87. Faculty Opinions recommendation of A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease.
    Jonathan P. Jacobs · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
88. Pathophysiologie: Mikrobiom
    Monika Rau · 2022 · Springer eBooks
89. Hígado graso: una epidemia silente
    Jhon Edison Prieto Ortíz · 2022 · Medicina
90. Mechanisms of nonalcoholic fatty liver disease induced by antibiotic resistance and evaluation of bacteriophag-efficacy
    Xi Jin, Jiusheng Wu, Chenghao Wang, Biao Tang, Hua Yang, Yuehuan Liu · 2023
91. Recent Updates in the Prevention of Nonalcoholic Fatty Liver Disease
    Mohamed El‐Kassas, Abeer Awad, Nahúm Méndez‐Sánchez · 2023 · Gene Expression
92. Unravelling the Environmental Variance of Litter Size Through the Genome and Gut Microbiome
    Cristina Casto‐Rebollo · 2023
93. Gut Microbiome and Hepatic Steatosis (Steatotic Liver Disease)
    Lesley Hoyles · 2024 · Endocrinology
94. Additional file 1 of Plasma metabolomics provides new insights into the relationship between metabolites and outcomes and left ventricular remodeling of coronary artery disease
    Zhu, Qian, Min Qin, Zixian Wang, Yonglin Wu, Xiaoping Chen, Chen Liu, Qilin Ma, Yibin Liu, Weihua Lai, Hui Chen et al. · 2022 · Figshare
95. An Integrated Genome-Metabolome-Mendelian Randomization Identifies Predictive Transcription Gene Signature of Liver Fibrosis
    Xiaoyan Wang, Lin Zhang, Yuhao Chang, Yuhuai Guo, Guangze Yang, Wenjun Xie, Min Zhu, Jisi Teng, Jessie Shen, Wei Jia et al. · 2024 · SSRN Electronic Journal
96. The Role of Gut Microbiota in Metabolic Dysfunction-Associated Fatty Liver Disease (MASLD)
    Săndica Bucurica · 2024 · IntechOpen eBooks
97. Research Progress on Rifaximin in Modulating Gut Microbiota for the Treatment of Nonalcoholic Fatty Liver Disease
    裕梅 范 · 2025 · Advances in Clinical Medicine
98. The association of advanced lung cancer inflammation index with non-alcoholic fatty liver disease in NHANES 2017–2020
    Lin Cheng, Shumeng Li, Hui Li, Jiafeng You, Mingwei Yu, Guowang Yang · 2025 · Frontiers in Medicine
99. Impact of tumour necrosis factor-α inhibitors on non-invasive indices of hepatic steatosis and fibrosis in patients with ankylosing spondylitis
    Dimitrios A. Anastasilakis, Grigorios Theocharis Sakellariou, Athanasios D. Anastasilakis, Ioanna Katsigianni, Eirini Pagkalidou, Stergios A. Pοlyzos · 2025 · Scandinavian Journal of Rheumatology
100. Additional file 2 of Commensal microbe-derived acetate suppresses NAFLD/NASH development via hepatic FFAR2 signalling in mice
     Ryo Aoki, Masayoshi Onuki, Koya Hattori, Ito, Masato, Yamada, Takahiro, Kohei Kamikado, Kim, Yun-Gi, Nakamoto, Nobuhiro, Kimura, Ikuo, Clarke, Julie M. et al. · 2021 · Figshare